Dr. Rangachari is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
330 Brookline Ave
Shapiro 9
Boston, MA 02215Phone+1 617-667-2100Fax+1 617-667-2518
Education & Training
Johns Hopkins UniversityFellowship, Hematology and Medical Oncology, 2010 - 2014- Johns Hopkins UniversityChief Residency, Internal Medicine, 2011 - 2012
- Johns Hopkins UniversityResidency, Internal Medicine, 2007 - 2010
University of Chicago Division of the Biological Sciences The Pritzker School of MedicineClass of 2007
Certifications & Licensure
MA State Medical License 2014 - 2025
MD State Medical License 2010 - 2015- American Board of Internal Medicine Hematology
- American Board of Internal Medicine Medical Oncology
Clinical Trials
- Study of Olaparib and Temozolomide in Patients With Recurrent Small Cell Lung Cancer Following Failure of Prior Chemotherapy Start of enrollment: 2015 Oct 13
- Study of Rovalpituzumab Tesirine (SC16LD6.5) for Third-Line and Later Treatment of Subjects With Relapsed or Refractory Delta-Like Protein 3-Expressing Small Cell Lung Cancer Start of enrollment: 2016 Jan 25
Publications & Presentations
PubMed
- 75 citationsAssociation of Performance Status With Survival in Patients With Advanced Non-Small Cell Lung Cancer Treated With Pembrolizumab Monotherapy.Kartik Sehgal, Ritu R. Gill, Page Widick, Poorva Bindal, Danielle C. McDonald
JAMA Network Open. 2021-02-01 - 32 citationsSafety and efficacy of immune checkpoint inhibitors in patients with non-small cell lung cancer and hepatitis B or hepatitis C infection.Ana Pertejo-Fernandez, Biagio Ricciuti, Sarah P. Hammond, Francisco M. Marty, Gonzalo Recondo
Lung Cancer. 2020-02-24 - 119 citationsManagement of advanced non-small cell lung cancers with known mutations or rearrangements: latest evidence and treatment approaches.Meghan Shea, Daniel B. Costa, Deepa Rangachari
Therapeutic Advances in Respiratory Disease. 2016-04-01
Press Mentions
Paper Proposes New Community-Oriented Fellowship Training Model for Hematologists/OncologistsDecember 20th, 2022- A First-of-Its-Kind Opportunity to Integrate Training in Medical Oncology, Hematology, and Palliative CareJune 10th, 2022
Anti-PD-1 Success in Advanced NSCLC PersistsOctober 8th, 2019- Join now to see all
Professional Memberships
- Member
- Member
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
